Clarity ' s theranostic prostate cancer trial progresses at the highest dose level cohort
SYDNEY, Nov. 29, 2023. Clarity Pharmaceuticals ( " Clarity " ), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Children | Clinical Trials | Pharmaceuticals | Prostate Cancer